4.8 Review

Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications

Journal

FRONTIERS IN IMMUNOLOGY
Volume 12, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.582556

Keywords

SARS-CoV-2; COVID-19; infectious diseases; nutraceuticals; inflammation

Categories

Ask authors/readers for more resources

Although a specific and effective cure for COVID-19 is still in progress, selected nutraceuticals could be helpful in preventing some COVID-19-related complications in infected patients, in addition to pharmacological therapy.
Introduction Several months ago, Chinese authorities identified an atypical pneumonia in Wuhan city, province of Hubei (China) caused by a novel coronavirus (2019-nCoV or SARS-CoV-2). The WHO announced this new disease was to be known as COVID-19. Evidence Acquisition Several approaches are currently underway for the treatment of this disease, but a specific cure remains to be established. Evidence Synthesis This review will describe how the use of selected nutraceuticals could be helpful, in addition to pharmacological therapy, in preventing some COVID-19-related complications in infected patients. Conclusions Even if a specific and effective cure for COVID-19 still has some way to go, selected nutraceuticals could be helpful, in addition to pharmacological therapy, in preventing some COVID-19-related complications in infected patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Glyco-metabolic control, inflammation markers, and cardiovascular outcomes in type 1 and type 2 diabetic patients on insulin pump or multiple daily injection (italico study)

Giuseppe Derosa, Gabriele Catena, Laura Scelsi, Angela D'Angelo, Riccardo Raddino, Eugenio Cosentino, Antonio Maggi, Gianfranco Pasini, Claudio Borghi, Pamela Maffioli

DIABETES-METABOLISM RESEARCH AND REVIEWS (2020)

Article Chemistry, Medicinal

Ilex paraguariensis, white mulberry and chromium picolinate in patients with pre-diabetes

Giuseppe Derosa, Angela D'Angelo, Pamela Maffioli

PHYTOTHERAPY RESEARCH (2020)

Review Cardiac & Cardiovascular Systems

Lipid-lowering nutraceuticals update on scientific evidence

Giuseppe Derosa, Alessandro Colletti, Pamela Maffioli, Angela D'Angelo, Alessandro Lupi, Giovanni B. Zito, Gian Francesco Mureddu, Riccardo Raddino, Francesco Fedele, Arrigo F. G. Cicero

JOURNAL OF CARDIOVASCULAR MEDICINE (2020)

Review Chemistry, Medicinal

A role for quercetin in coronavirus disease 2019 (COVID-19)

Giuseppe Derosa, Pamela Maffioli, Angela D'Angelo, Francesco Di Pierro

Summary: COVID-19, caused by novel coronavirus (SARS-CoV-2), was first detected in Wuhan City, China. Quercetin has the potential to inhibit virus replication and possesses anti-inflammatory and thrombin-inhibitory actions.

PHYTOTHERAPY RESEARCH (2021)

Article Nutrition & Dietetics

Abscisic Acid Treatment in Patients with Prediabetes

Giuseppe Derosa, Pamela Maffioli, Angela D'Angelo, Paola S. Preti, Giancarlo Tenore, Ettore Novellino

NUTRIENTS (2020)

Article Chemistry, Medicinal

Safety and Efficacy of Alpha Lipoic Acid During 4 Years of Observation: A Retrospective, Clinical Trial in Healthy Subjects in Primary Prevention

Giuseppe Derosa, Angela D'Angelo, Paola Preti, Pamela Maffioli

DRUG DESIGN DEVELOPMENT AND THERAPY (2020)

Article Medicine, General & Internal

Psoriasis and Diabetes, a Dangerous Association: Evaluation of Insulin Resistance, Lipid Abnormalities, and Cardiovascular Risk Biomarkers

Valeria Brazzelli, Pamela Maffioli, Vittorio Bolcato, Christian Ciolfi, Angela D. Angelo, Carmine Tinelli, Giuseppe Derosa

Summary: This study found that diabetic patients with psoriasis exhibited higher levels of insulin resistance, lipid abnormalities, and cardiovascular risk compared to other patient groups and healthy subjects, suggesting a potential pathogenic link between psoriasis and diabetes.

FRONTIERS IN MEDICINE (2021)

Article Medicine, General & Internal

Effects of experimental colitis in rats on incretin levels, inflammatory markers, and enteric neuronal function

Giuseppe Derosa, Pamela Maffioli, Angela D'Angelo, Giovanna Cipolla, Elisabetta Moro, Francesca Crema

Summary: This study assessed the effects of chronic inflammation on incretin levels, inflammatory markers, and enteric neuronal function in rat smooth muscle preparations. The results showed that chronic inflammation led to increased levels of incretin hormones and decreased functional response of colon intestinal smooth muscle after electrical stimulation.

ARCHIVES OF MEDICAL SCIENCE (2021)

Article Biology

Metabolic Actions of a Supplement of Ilex Paraguariensis (An Extract of the Leaf Standardized to 2% I-Deoxinojirimcina), White Mulberry and Chromium Picolinate in Nondiabetic Subects with Dysglycemia: A Randomized Trial

Giuseppe Derosa, Angela D'Angelo, Pamela Maffioli

Summary: The study demonstrates that a nutraceutical containing Ilex paraguariensis, white mulberry, and chromium picolinate can significantly improve glycemic status and lipid profiles, benefiting patients with dysglycemia.

LIFE-BASEL (2021)

Article Medicine, General & Internal

Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial

Francesco Di Pierro, Somia Iqtadar, Amjad Khan, Sami Ullah Mumtaz, Mohsin Masud Chaudhry, Alexander Bertuccioli, Giuseppe Derosa, Pamela Maffioli, Stefano Togni, Antonella Riva, Pietro Allegrini, Saeed Khan

Summary: Treatment with QP in COVID-19 patients can lead to faster virus clearance, reduced symptoms severity, and improved blood parameters, showing promising potential as a therapeutic intervention for the disease.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)

Article Medicine, General & Internal

Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study

Francesco Di Pierro, Giuseppe Derosa, Pamela Maffioli, Alexander Bertuccioli, Stefano Togni, Antonella Riva, Pietro Allegrini, Amjad Khan, Saeed Khan, Bilal Ahmad Khan, Naireen Altaf, Maria Zahid, Ikram Din Ujjan, Roohi Nigar, Mehwish Imam Khushk, Maryam Phulpoto, Amanullah Lail, Bikha Ram Devrajani, Sagheer Ahmed

Summary: The study indicates that Quercetin Phytosome may have potential therapeutic effects for COVID-19 patients, reducing hospitalization and mortality rates. It is also shown to be safe and may have anti-fatigue and appetite-enhancing properties.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)

Review Biochemistry & Molecular Biology

Detection of sieric BAG3 in patients affected by cardiovascular diseases: State of art and perspectives

Pamela Maffioli, Angela D'Angelo, Carmine Tinelli, Colomba Falcone, Gennaro Galasso, Giuseppe Derosa

Summary: The study found a significant correlation between BAG3 serum levels and dyslipidemia and diabetic disease in AMI patients, while no significant correlations were observed with smoking habit, hypertension, or familiarity for AMI. Some patients were BAG3-positive and characterized by particular features such as comorbidity presence or concomitant therapies.

JOURNAL OF CELLULAR BIOCHEMISTRY (2022)

Review Chemistry, Medicinal

The role of selected nutraceuticals in management of prediabetes and diabetes: An updated review of the literature

Giuseppe Derosa, Angela D'Angelo, Pamela Maffioli

Summary: This review analyzed clinical trial results on the effects of nutraceuticals on blood glucose management. The study found that some nutraceuticals have positive impacts on glycemia, while the effects of others are still controversial and require further long-term clinical trials for confirmation.

PHYTOTHERAPY RESEARCH (2022)

Review Gastroenterology & Hepatology

Quercetin Phytosome® as a potential candidate for managing COVID-19

Francesco Di Pierro, Amjad Khan, Alexander Bertuccioli, Pamela Maffioli, Giuseppe Derosa, Saeed Khan, Bilal A. Khan, Roohi Nigar, Ikram Ujjan, Bikha R. Devrajani

Summary: Research has shown that quercetin may be an important antiviral compound against COVID-19, but its low oral bioavailability presents a challenge. A phospholipid delivery form of quercetin is being tested to address this issue and improve its potential as a candidate for clinical treatment of COVID-19.

MINERVA GASTROENTEROLOGY (2021)

No Data Available